B-Complex — Class II drug recall D-0284-2022
Terminated recall by Valgene Incorporated dba Cape Drugs, reported 2021-12-22, distributed in MD. Lack of Processing Controls
| Recall number | D-0284-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Valgene Incorporated dba Cape Drugs, Annapolis, MD, United States |
| Recall initiated | 2021-12-03 |
| Classified | 2021-12-15 |
| Reported by FDA | 2021-12-22 |
| Terminated | 2022-01-04 |
| Distributed | MD |
| Quantity | 12 vials |
| Lot numbers | 190036 |
| Expiration dates | 2021-12-27 |
Product
B-Complex, injection, 1 mL vials, Rx only, Cape Drugs 1384 Cape St. Claire Road Annapolis, MD 21409
Reason for recall
Lack of Processing Controls
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0284-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.